73 related articles for article (PubMed ID: 4986820)
1. [Absorption of Cr51-EDTA from the colon in normal persons and in patients with ulcerative colitis. Preliminary report].
Rask-Madsen J; Schwartz M
Ugeskr Laeger; 1970 May; 132(22):1032-7. PubMed ID: 4986820
[No Abstract] [Full Text] [Related]
2. Absorption of 51Cr-EDTA in ulcerative colitis following rectal instillation.
Rask-Madsen J; Schwartz M
Scand J Gastroenterol; 1970; 5(5):361-8. PubMed ID: 4989516
[No Abstract] [Full Text] [Related]
3. Simultaneous measurement of electrical polarization and electrolyte transport by the entire normal and inflamed human colon during in vivo perfusion.
Rask-Madsen J
Scand J Gastroenterol; 1973; 8(4):327-36. PubMed ID: 4729203
[No Abstract] [Full Text] [Related]
4. Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.
Bjarnason I; O'Morain C; Levi AJ; Peters TJ
Gastroenterology; 1983 Aug; 85(2):318-22. PubMed ID: 6407889
[TBL] [Abstract][Full Text] [Related]
5. Rectal electrolyte transport and mucosal permeability in ulcerative colitis and Crohn's disease.
Rask-Madsen J; Hammersgaard EA; Knudsen E
J Lab Clin Med; 1973 Mar; 81(3):342-53. PubMed ID: 4631401
[No Abstract] [Full Text] [Related]
6. [Absorption function of the large intestine in patients with nonspecific ulcerative colitis].
Osina VA; Rogozina VA; Sil'vestrova SIu
Eksp Klin Gastroenterol; 2002; (2):88-91, 104. PubMed ID: 12046397
[TBL] [Abstract][Full Text] [Related]
7. Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis.
Sandle GI; Perry MD; Mathialahan T; Linley JE; Robinson P; Hunter M; MacLennan KA
J Pathol; 2007 May; 212(1):66-73. PubMed ID: 17405186
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis.
Smithson JE; Warren BF; Young S; Pigott R; Jewell DP
J Pathol; 1996 Oct; 180(2):146-51. PubMed ID: 8976872
[TBL] [Abstract][Full Text] [Related]
9. Increased oxidation of a chemical carcinogen, benzo(a)pyrene, by colon tissue biopsy specimens from patients with ulcerative colitis.
Mayhew JW; Lombardi PE; Fawaz K; Goldin B; Foster EA; Goldberg M; Sepersky R; Kellum JM; Gorbach SL
Gastroenterology; 1983 Aug; 85(2):328-34. PubMed ID: 6305757
[TBL] [Abstract][Full Text] [Related]
10. Intestinal permeability to 51Cr-ethylenediaminetetraacetate in patients with ulcerative colitis.
Zuckerman MJ; Watts MT
Am J Gastroenterol; 1993 Nov; 88(11):1978-9. PubMed ID: 8237961
[No Abstract] [Full Text] [Related]
11. [Less of Cr-51 albumin into the digestive tract in patients with ulcerative colitis].
Tkaczewski W; Stempień R; Niedzielska H; Kuydowicz J
Pol Tyg Lek; 1974 Jun; 29(25):1065-6. PubMed ID: 4842711
[No Abstract] [Full Text] [Related]
12. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease.
Issenman RM; Jenkins RT; Radoja C
Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046
[TBL] [Abstract][Full Text] [Related]
13. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
14. Decreased transmural potential difference across the human rectum in ulcerative colits.
Rask-Madsen J; Dalmark M
Scand J Gastroenterol; 1973; 8(4):321-6. PubMed ID: 4729202
[No Abstract] [Full Text] [Related]
15. Intraluminal colonic levels of arachidonic acid metabolites in ulcerative colitis.
Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():347-52. PubMed ID: 2959077
[No Abstract] [Full Text] [Related]
16. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
17. [Expression with TGFbeta1 in the patients with ulcerative colitis].
Wang YF; Wei B; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):204-6. PubMed ID: 15807267
[TBL] [Abstract][Full Text] [Related]
18. Peptidergic nerves in the colon of patients with ulcerative colitis.
Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M
Hepatogastroenterology; 2000; 47(32):400-4. PubMed ID: 10791200
[TBL] [Abstract][Full Text] [Related]
19. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
[TBL] [Abstract][Full Text] [Related]
20. [Immunomorphological characteristics of mucosal and endocrine cells of the colon in patients with chronic ulcerative colitis].
Rybakova MG; Botina AV; Solov'eva OI
Arkh Patol; 2005; 67(2):30-3. PubMed ID: 15938117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
